These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 9476376)

  • 1. [Is beta 2-microglobulin a marker of bone remodeling in Paget's disease of bone?].
    Wilczek H
    Cas Lek Cesk; 1997 Dec; 136(23):730-2. PubMed ID: 9476376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta-2-microglobulin in diseases with high bone remodeling.
    Ripoll E; Arribas I; Relea P; Varela L; Villa LF; Revilla M; Rico H
    Calcif Tissue Int; 1995 Oct; 57(4):272-6. PubMed ID: 8673864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of intravenous pamidronate therapy on Paget's disease of bone.
    Bombassei GJ; Yocono M; Raisz LG
    Am J Med Sci; 1994 Oct; 308(4):226-33. PubMed ID: 7942981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Symptomatic and scintigraphic improvement after intravenous pamidronate treatment of Paget's disease of bone in patients with normal serum alkaline phosphatase levels.
    Ang G; Feiglin D; Moses AM
    Endocr Pract; 2003; 9(4):280-3. PubMed ID: 14561571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenously administered pamidronate in the treatment of Paget's disease of bone.
    Tucci JR; Bontha S
    Endocr Pract; 2001; 7(6):423-9. PubMed ID: 11747277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. beta 2-Microglobulin in Paget's bone disease.
    Rico H; Ripoll E; Arribas I; Revilla M; Relea P; Villa LF; de Buergo MA
    Calcif Tissue Int; 1994 May; 54(5):389-91. PubMed ID: 8062156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of Paget's disease of bone with single dose intravenous pamidronate.
    Watts RA; Skingle SJ; Bhambhani MM; Pountain G; Crisp AJ
    Ann Rheum Dis; 1993 Aug; 52(8):616-8. PubMed ID: 8215628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in serum HDL and LDL cholesterol in patients with Paget's bone disease treated with pamidronate.
    Montagnani A; Gonnelli S; Cepollaro C; Campagna MS; Franci MB; Pacini S; Gennari C
    Bone; 2003 Jan; 32(1):15-9. PubMed ID: 12584031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone turnover markers in Paget's disease of the bone: A Systematic review and meta-analysis.
    Al Nofal AA; Altayar O; BenKhadra K; Qasim Agha OQ; Asi N; Nabhan M; Prokop LJ; Tebben P; Murad MH
    Osteoporos Int; 2015 Jul; 26(7):1875-91. PubMed ID: 26037791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum osteoprotegerin and its ligand in Paget's disease of bone: relationship to disease activity and effect of treatment with bisphosphonates.
    Alvarez L; Peris P; Guañabens N; Vidal S; Ros I; Pons F; Filella X; Monegal A; Muñoz-Gomez J; Ballesta AM
    Arthritis Rheum; 2003 Mar; 48(3):824-8. PubMed ID: 12632438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical experience with pamidronate in the treatment of Paget's disease of bone.
    Gallacher SJ; Boyce BF; Patel U; Jenkins A; Ralston SH; Boyle IT
    Ann Rheum Dis; 1991 Dec; 50(12):930-3. PubMed ID: 1768163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paget's disease of the bone: a report of three cases.
    Bhatt K; Balakrishnan C; Mangat G; Bajan K; Ashavaid T; Joshi VR
    J Assoc Physicians India; 2006 Jul; 54():571-4. PubMed ID: 17089908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful treatment of resistant Paget's disease of bone with pamidronate.
    Mallette LE
    Arch Intern Med; 1989 Dec; 149(12):2765-7. PubMed ID: 2596945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Bisphosphonate therapy of Paget's disease of bone with pamidronate].
    Grauer A; Klar B; Knaus J; Scharla SH; Ziegler R
    Med Klin (Munich); 1996 Jan; 91(1):14-9. PubMed ID: 8839196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paget's disease of bone: five regimens of pamidronate treatment.
    Pepersack T; Karmali R; Gillet C; François D; Fuss M
    Clin Rheumatol; 1994 Mar; 13(1):39-44. PubMed ID: 8187442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of the serum levels of bone alkaline phosphatase with a new immunoradiometric assay in patients with metabolic bone disease.
    Garnero P; Delmas PD
    J Clin Endocrinol Metab; 1993 Oct; 77(4):1046-53. PubMed ID: 8104954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative bone scintigraphy in the management of monostotic Paget's disease of bone.
    Patel S; Pearson D; Hosking DJ
    Arthritis Rheum; 1995 Oct; 38(10):1506-12. PubMed ID: 7575701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [What do we know about the significance of vitamin D in Paget's disease of the bone?].
    Wilczek H; Stĕpán J; Justová V
    Cas Lek Cesk; 1995 Dec; 134(24):785-7. PubMed ID: 8599821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis and treatment of Paget's disease of bone : A clinical practice guideline.
    Muschitz C; Feichtinger X; Haschka J; Kocijan R
    Wien Med Wochenschr; 2017 Feb; 167(1-2):18-24. PubMed ID: 27600563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-dose pamidronate in the management of resistant Paget's disease.
    Cundy T; Wattie D; King AR
    Calcif Tissue Int; 1996 Jan; 58(1):6-8. PubMed ID: 8825232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.